The global Vaccine for Influenza market is projected to grow from US$ 8529.8 million in 2024 to US$ 11760 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.

Vaccine for Influenza Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Vaccine for Influenza, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Vaccine for Influenza, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Vaccine for Influenza, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vaccine for Influenza sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccine for Influenza market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Vaccine for Influenza sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Vaccine for Influenza Market Report

Report Metric	Details
Report Name	Vaccine for Influenza Market
Accounted market size in 2024	US$ 8529.8 million
Forecasted market size in 2030	US$ 11760 million
CAGR	5.5
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Trivalent Influenza Vaccine Quadrivalent Influenza Vaccine
Segment by Application	For Children (6 months to 3 years) For Adults and Children over 3 years
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Vaccine for Influenza in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Vaccine for Influenza manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine for Influenza sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Vaccine for Influenza Market growing?

Ans: The Vaccine for Influenza Market witnessing a CAGR of 5.5 during the forecast period 2025-2030.

What is the Vaccine for Influenza Market size in 2030?

Ans: The Vaccine for Influenza Market size in 2030 will be US$ 11760 million.

Who are the main players in the Vaccine for Influenza Market report?

Ans: The main players in the Vaccine for Influenza Market are GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Vaccine for Influenza Market report?

Ans: The Applications covered in the Vaccine for Influenza Market report are For Children (6 months to 3 years), For Adults and Children over 3 years

What are the Type segmentation covered in the Vaccine for Influenza Market report?

Ans: The Types covered in the Vaccine for Influenza Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

1 Study Coverage

1.1 Vaccine for Influenza Product Introduction

1.2 Market by Type

1.2.1 Global Vaccine for Influenza Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Market by Application

1.3.1 Global Vaccine for Influenza Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 For Children (6 months to 3 years)

1.3.3 For Adults and Children over 3 years

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Vaccine for Influenza Sales Estimates and Forecasts 2019-2030

2.2 Global Vaccine for Influenza Revenue by Region

2.2.1 Global Vaccine for Influenza Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Vaccine for Influenza Revenue by Region (2019-2024)

2.2.3 Global Vaccine for Influenza Revenue by Region (2025-2030)

2.2.4 Global Vaccine for Influenza Revenue Market Share by Region (2019-2030)

2.3 Global Vaccine for Influenza Sales Estimates and Forecasts 2019-2030

2.4 Global Vaccine for Influenza Sales by Region

2.4.1 Global Vaccine for Influenza Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Vaccine for Influenza Sales by Region (2019-2024)

2.4.3 Global Vaccine for Influenza Sales by Region (2025-2030)

2.4.4 Global Vaccine for Influenza Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Vaccine for Influenza Sales by Manufacturers

3.1.1 Global Vaccine for Influenza Sales by Manufacturers (2019-2024)

3.1.2 Global Vaccine for Influenza Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine for Influenza in 2023

3.2 Global Vaccine for Influenza Revenue by Manufacturers

3.2.1 Global Vaccine for Influenza Revenue by Manufacturers (2019-2024)

3.2.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Vaccine for Influenza Revenue in 2023

3.3 Global Key Players of Vaccine for Influenza, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Vaccine for Influenza Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Vaccine for Influenza, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Vaccine for Influenza, Product Offered and Application

3.8 Global Key Manufacturers of Vaccine for Influenza, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Vaccine for Influenza Sales by Type

4.1.1 Global Vaccine for Influenza Historical Sales by Type (2019-2024)

4.1.2 Global Vaccine for Influenza Forecasted Sales by Type (2025-2030)

4.1.3 Global Vaccine for Influenza Sales Market Share by Type (2019-2030)

4.2 Global Vaccine for Influenza Revenue by Type

4.2.1 Global Vaccine for Influenza Historical Revenue by Type (2019-2024)

4.2.2 Global Vaccine for Influenza Forecasted Revenue by Type (2025-2030)

4.2.3 Global Vaccine for Influenza Revenue Market Share by Type (2019-2030)

4.3 Global Vaccine for Influenza Price by Type

4.3.1 Global Vaccine for Influenza Price by Type (2019-2024)

4.3.2 Global Vaccine for Influenza Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Vaccine for Influenza Sales by Application

5.1.1 Global Vaccine for Influenza Historical Sales by Application (2019-2024)

5.1.2 Global Vaccine for Influenza Forecasted Sales by Application (2025-2030)

5.1.3 Global Vaccine for Influenza Sales Market Share by Application (2019-2030)

5.2 Global Vaccine for Influenza Revenue by Application

5.2.1 Global Vaccine for Influenza Historical Revenue by Application (2019-2024)

5.2.2 Global Vaccine for Influenza Forecasted Revenue by Application (2025-2030)

5.2.3 Global Vaccine for Influenza Revenue Market Share by Application (2019-2030)

5.3 Global Vaccine for Influenza Price by Application

5.3.1 Global Vaccine for Influenza Price by Application (2019-2024)

5.3.2 Global Vaccine for Influenza Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Vaccine for Influenza Market Size by Type

6.1.1 US & Canada Vaccine for Influenza Sales by Type (2019-2030)

6.1.2 US & Canada Vaccine for Influenza Revenue by Type (2019-2030)

6.2 US & Canada Vaccine for Influenza Market Size by Application

6.2.1 US & Canada Vaccine for Influenza Sales by Application (2019-2030)

6.2.2 US & Canada Vaccine for Influenza Revenue by Application (2019-2030)

6.3 US & Canada Vaccine for Influenza Market Size by Country

6.3.1 US & Canada Vaccine for Influenza Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Vaccine for Influenza Sales by Country (2019-2030)

6.3.3 US & Canada Vaccine for Influenza Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Vaccine for Influenza Market Size by Type

7.1.1 Europe Vaccine for Influenza Sales by Type (2019-2030)

7.1.2 Europe Vaccine for Influenza Revenue by Type (2019-2030)

7.2 Europe Vaccine for Influenza Market Size by Application

7.2.1 Europe Vaccine for Influenza Sales by Application (2019-2030)

7.2.2 Europe Vaccine for Influenza Revenue by Application (2019-2030)

7.3 Europe Vaccine for Influenza Market Size by Country

7.3.1 Europe Vaccine for Influenza Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Vaccine for Influenza Sales by Country (2019-2030)

7.3.3 Europe Vaccine for Influenza Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Vaccine for Influenza Market Size

8.1.1 China Vaccine for Influenza Sales (2019-2030)

8.1.2 China Vaccine for Influenza Revenue (2019-2030)

8.2 China Vaccine for Influenza Market Size by Application

8.2.1 China Vaccine for Influenza Sales by Application (2019-2030)

8.2.2 China Vaccine for Influenza Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Vaccine for Influenza Market Size by Type

9.1.1 Asia Vaccine for Influenza Sales by Type (2019-2030)

9.1.2 Asia Vaccine for Influenza Revenue by Type (2019-2030)

9.2 Asia Vaccine for Influenza Market Size by Application

9.2.1 Asia Vaccine for Influenza Sales by Application (2019-2030)

9.2.2 Asia Vaccine for Influenza Revenue by Application (2019-2030)

9.3 Asia Vaccine for Influenza Sales by Region

9.3.1 Asia Vaccine for Influenza Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Vaccine for Influenza Revenue by Region (2019-2030)

9.3.3 Asia Vaccine for Influenza Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Vaccine for Influenza Market Size by Type

10.1.1 Middle East, Africa and Latin America Vaccine for Influenza Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Vaccine for Influenza Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Vaccine for Influenza Market Size by Application

10.2.1 Middle East, Africa and Latin America Vaccine for Influenza Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Vaccine for Influenza Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Vaccine for Influenza Sales by Country

10.3.1 Middle East, Africa and Latin America Vaccine for Influenza Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Vaccine for Influenza Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Vaccine for Influenza Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Sanofi

11.1.1 Sanofi Company Information

11.1.2 Sanofi Overview

11.1.3 Sanofi Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Sanofi Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sanofi Recent Developments

11.2 CSL

11.2.1 CSL Company Information

11.2.2 CSL Overview

11.2.3 CSL Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 CSL Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 CSL Recent Developments

11.3 GSK

11.3.1 GSK Company Information

11.3.2 GSK Overview

11.3.3 GSK Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 GSK Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 GSK Recent Developments

11.4 Viatris

11.4.1 Viatris Company Information

11.4.2 Viatris Overview

11.4.3 Viatris Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Viatris Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Viatris Recent Developments

11.5 AstraZeneca

11.5.1 AstraZeneca Company Information

11.5.2 AstraZeneca Overview

11.5.3 AstraZeneca Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 AstraZeneca Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 AstraZeneca Recent Developments

11.6 Hualan Bio

11.6.1 Hualan Bio Company Information

11.6.2 Hualan Bio Overview

11.6.3 Hualan Bio Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Hualan Bio Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Hualan Bio Recent Developments

11.7 Changchun Institute of Biological

11.7.1 Changchun Institute of Biological Company Information

11.7.2 Changchun Institute of Biological Overview

11.7.3 Changchun Institute of Biological Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Changchun Institute of Biological Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Changchun Institute of Biological Recent Developments

11.8 Sinovac

11.8.1 Sinovac Company Information

11.8.2 Sinovac Overview

11.8.3 Sinovac Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Sinovac Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Sinovac Recent Developments

11.9 BCHT

11.9.1 BCHT Company Information

11.9.2 BCHT Overview

11.9.3 BCHT Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 BCHT Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 BCHT Recent Developments

11.10 Jiangsu GDK

11.10.1 Jiangsu GDK Company Information

11.10.2 Jiangsu GDK Overview

11.10.3 Jiangsu GDK Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Jiangsu GDK Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Jiangsu GDK Recent Developments

11.11 KM Biologics

11.11.1 KM Biologics Company Information

11.11.2 KM Biologics Overview

11.11.3 KM Biologics Vaccine for Influenza Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 KM Biologics Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 KM Biologics Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Vaccine for Influenza Industry Chain Analysis

12.2 Vaccine for Influenza Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Vaccine for Influenza Production Mode & Process

12.4 Vaccine for Influenza Sales and Marketing

12.4.1 Vaccine for Influenza Sales Channels

12.4.2 Vaccine for Influenza Distributors

12.5 Vaccine for Influenza Customers

13 Market Dynamics

13.1 Vaccine for Influenza Industry Trends

13.2 Vaccine for Influenza Market Drivers

13.3 Vaccine for Influenza Market Challenges

13.4 Vaccine for Influenza Market Restraints

14 Key Findings in The Global Vaccine for Influenza Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Changchun Institute of Biological

List of Tables

Table 1. Global Vaccine for Influenza Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Trivalent Influenza Vaccine

Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine

Table 4. Global Vaccine for Influenza Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Vaccine for Influenza Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Vaccine for Influenza Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Vaccine for Influenza Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Vaccine for Influenza Revenue Market Share by Region (2019-2024)

Table 9. Global Vaccine for Influenza Revenue Market Share by Region (2025-2030)

Table 10. Global Vaccine for Influenza Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Vaccine for Influenza Sales by Region (2019-2024) & (K Units)

Table 12. Global Vaccine for Influenza Sales by Region (2025-2030) & (K Units)

Table 13. Global Vaccine for Influenza Sales Market Share by Region (2019-2024)

Table 14. Global Vaccine for Influenza Sales Market Share by Region (2025-2030)

Table 15. Global Vaccine for Influenza Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Vaccine for Influenza Sales Share by Manufacturers (2019-2024)

Table 17. Global Vaccine for Influenza Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Vaccine for Influenza Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Vaccine for Influenza, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Vaccine for Influenza Price by Manufacturers 2019-2024 (US$/Unit)

Table 21. Global Vaccine for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Vaccine for Influenza by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Influenza as of 2023)

Table 23. Global Key Manufacturers of Vaccine for Influenza, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Vaccine for Influenza, Product Offered and Application

Table 25. Global Key Manufacturers of Vaccine for Influenza, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Vaccine for Influenza Sales by Type (2019-2024) & (K Units)

Table 28. Global Vaccine for Influenza Sales by Type (2025-2030) & (K Units)

Table 29. Global Vaccine for Influenza Sales Share by Type (2019-2024)

Table 30. Global Vaccine for Influenza Sales Share by Type (2025-2030)

Table 31. Global Vaccine for Influenza Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Vaccine for Influenza Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Vaccine for Influenza Revenue Share by Type (2019-2024)

Table 34. Global Vaccine for Influenza Revenue Share by Type (2025-2030)

Table 35. Vaccine for Influenza Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Vaccine for Influenza Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Vaccine for Influenza Sales by Application (2019-2024) & (K Units)

Table 38. Global Vaccine for Influenza Sales by Application (2025-2030) & (K Units)

Table 39. Global Vaccine for Influenza Sales Share by Application (2019-2024)

Table 40. Global Vaccine for Influenza Sales Share by Application (2025-2030)

Table 41. Global Vaccine for Influenza Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Vaccine for Influenza Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Vaccine for Influenza Revenue Share by Application (2019-2024)

Table 44. Global Vaccine for Influenza Revenue Share by Application (2025-2030)

Table 45. Vaccine for Influenza Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Vaccine for Influenza Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Vaccine for Influenza Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Vaccine for Influenza Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Vaccine for Influenza Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Vaccine for Influenza Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Vaccine for Influenza Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Vaccine for Influenza Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Vaccine for Influenza Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Vaccine for Influenza Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Vaccine for Influenza Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Vaccine for Influenza Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Vaccine for Influenza Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Vaccine for Influenza Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Vaccine for Influenza Sales by Country (2025-2030) & (K Units)

Table 60. Europe Vaccine for Influenza Sales by Type (2019-2024) & (K Units)

Table 61. Europe Vaccine for Influenza Sales by Type (2025-2030) & (K Units)

Table 62. Europe Vaccine for Influenza Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Vaccine for Influenza Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Vaccine for Influenza Sales by Application (2019-2024) & (K Units)

Table 65. Europe Vaccine for Influenza Sales by Application (2025-2030) & (K Units)

Table 66. Europe Vaccine for Influenza Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Vaccine for Influenza Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Vaccine for Influenza Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Vaccine for Influenza Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Vaccine for Influenza Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Vaccine for Influenza Sales by Country (2019-2024) & (K Units)

Table 72. Europe Vaccine for Influenza Sales by Country (2025-2030) & (K Units)

Table 73. China Vaccine for Influenza Sales by Type (2019-2024) & (K Units)

Table 74. China Vaccine for Influenza Sales by Type (2025-2030) & (K Units)

Table 75. China Vaccine for Influenza Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Vaccine for Influenza Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Vaccine for Influenza Sales by Application (2019-2024) & (K Units)

Table 78. China Vaccine for Influenza Sales by Application (2025-2030) & (K Units)

Table 79. China Vaccine for Influenza Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Vaccine for Influenza Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Vaccine for Influenza Sales by Type (2019-2024) & (K Units)

Table 82. Asia Vaccine for Influenza Sales by Type (2025-2030) & (K Units)

Table 83. Asia Vaccine for Influenza Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Vaccine for Influenza Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Vaccine for Influenza Sales by Application (2019-2024) & (K Units)

Table 86. Asia Vaccine for Influenza Sales by Application (2025-2030) & (K Units)

Table 87. Asia Vaccine for Influenza Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Vaccine for Influenza Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Vaccine for Influenza Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Vaccine for Influenza Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Vaccine for Influenza Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Vaccine for Influenza Sales by Region (2019-2024) & (K Units)

Table 93. Asia Vaccine for Influenza Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Vaccine for Influenza Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Vaccine for Influenza Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Vaccine for Influenza Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Vaccine for Influenza Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Vaccine for Influenza Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Vaccine for Influenza Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Vaccine for Influenza Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Vaccine for Influenza Sales by Country (2025-2030) & (K Units)

Table 107. Sanofi Company Information

Table 108. Sanofi Description and Major Businesses

Table 109. Sanofi Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Sanofi Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Sanofi Recent Developments

Table 112. CSL Company Information

Table 113. CSL Description and Major Businesses

Table 114. CSL Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. CSL Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. CSL Recent Developments

Table 117. GSK Company Information

Table 118. GSK Description and Major Businesses

Table 119. GSK Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. GSK Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. GSK Recent Developments

Table 122. Viatris Company Information

Table 123. Viatris Description and Major Businesses

Table 124. Viatris Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Viatris Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Viatris Recent Developments

Table 127. AstraZeneca Company Information

Table 128. AstraZeneca Description and Major Businesses

Table 129. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. AstraZeneca Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. AstraZeneca Recent Developments

Table 132. Hualan Bio Company Information

Table 133. Hualan Bio Description and Major Businesses

Table 134. Hualan Bio Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Hualan Bio Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Hualan Bio Recent Developments

Table 137. Changchun Institute of Biological Company Information

Table 138. Changchun Institute of Biological Description and Major Businesses

Table 139. Changchun Institute of Biological Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. Changchun Institute of Biological Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Changchun Institute of Biological Recent Developments

Table 142. Sinovac Company Information

Table 143. Sinovac Description and Major Businesses

Table 144. Sinovac Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 145. Sinovac Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Sinovac Recent Developments

Table 147. BCHT Company Information

Table 148. BCHT Description and Major Businesses

Table 149. BCHT Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 150. BCHT Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. BCHT Recent Developments

Table 152. Jiangsu GDK Company Information

Table 153. Jiangsu GDK Description and Major Businesses

Table 154. Jiangsu GDK Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 155. Jiangsu GDK Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Jiangsu GDK Recent Developments

Table 157. KM Biologics Company Information

Table 158. KM Biologics Description and Major Businesses

Table 159. KM Biologics Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 160. KM Biologics Vaccine for Influenza Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. KM Biologics Recent Developments

Table 162. Key Raw Materials Lists

Table 163. Raw Materials Key Suppliers Lists

Table 164. Vaccine for Influenza Distributors List

Table 165. Vaccine for Influenza Customers List

Table 166. Vaccine for Influenza Market Trends

Table 167. Vaccine for Influenza Market Drivers

Table 168. Vaccine for Influenza Market Challenges

Table 169. Vaccine for Influenza Market Restraints

Table 170. Research Programs/Design for This Report

Table 171. Key Data Information from Secondary Sources

Table 172. Key Data Information from Primary Sources

List of Figures

Figure 1. Vaccine for Influenza Product Picture

Figure 2. Global Vaccine for Influenza Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Vaccine for Influenza Market Share by Type in 2023 & 2030

Figure 4. Trivalent Influenza Vaccine Product Picture

Figure 5. Quadrivalent Influenza Vaccine Product Picture

Figure 6. Global Vaccine for Influenza Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Vaccine for Influenza Market Share by Application in 2023 & 2030

Figure 8. For Children (6 months to 3 years)

Figure 9. For Adults and Children over 3 years

Figure 10. Vaccine for Influenza Report Years Considered

Figure 11. Global Vaccine for Influenza Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Vaccine for Influenza Revenue 2019-2030 (US$ Million)

Figure 13. Global Vaccine for Influenza Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Vaccine for Influenza Revenue Market Share by Region (2019-2030)

Figure 15. Global Vaccine for Influenza Sales 2019-2030 ((K Units)

Figure 16. Global Vaccine for Influenza Sales Market Share by Region (2019-2030)

Figure 17. US & Canada Vaccine for Influenza Sales YoY (2019-2030) & (K Units)

Figure 18. US & Canada Vaccine for Influenza Revenue YoY (2019-2030) & (US$ Million)

Figure 19. Europe Vaccine for Influenza Sales YoY (2019-2030) & (K Units)

Figure 20. Europe Vaccine for Influenza Revenue YoY (2019-2030) & (US$ Million)

Figure 21. China Vaccine for Influenza Sales YoY (2019-2030) & (K Units)

Figure 22. China Vaccine for Influenza Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Asia (excluding China) Vaccine for Influenza Sales YoY (2019-2030) & (K Units)

Figure 24. Asia (excluding China) Vaccine for Influenza Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Middle East, Africa and Latin America Vaccine for Influenza Sales YoY (2019-2030) & (K Units)

Figure 26. Middle East, Africa and Latin America Vaccine for Influenza Revenue YoY (2019-2030) & (US$ Million)

Figure 27. The Vaccine for Influenza Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 28. The Top 5 and 10 Largest Manufacturers of Vaccine for Influenza in the World: Market Share by Vaccine for Influenza Revenue in 2023

Figure 29. Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 30. Global Vaccine for Influenza Sales Market Share by Type (2019-2030)

Figure 31. Global Vaccine for Influenza Revenue Market Share by Type (2019-2030)

Figure 32. Global Vaccine for Influenza Sales Market Share by Application (2019-2030)

Figure 33. Global Vaccine for Influenza Revenue Market Share by Application (2019-2030)

Figure 34. US & Canada Vaccine for Influenza Sales Market Share by Type (2019-2030)

Figure 35. US & Canada Vaccine for Influenza Revenue Market Share by Type (2019-2030)

Figure 36. US & Canada Vaccine for Influenza Sales Market Share by Application (2019-2030)

Figure 37. US & Canada Vaccine for Influenza Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Vaccine for Influenza Revenue Share by Country (2019-2030)

Figure 39. US & Canada Vaccine for Influenza Sales Share by Country (2019-2030)

Figure 40. U.S. Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 41. Canada Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 42. Europe Vaccine for Influenza Sales Market Share by Type (2019-2030)

Figure 43. Europe Vaccine for Influenza Revenue Market Share by Type (2019-2030)

Figure 44. Europe Vaccine for Influenza Sales Market Share by Application (2019-2030)

Figure 45. Europe Vaccine for Influenza Revenue Market Share by Application (2019-2030)

Figure 46. Europe Vaccine for Influenza Revenue Share by Country (2019-2030)

Figure 47. Europe Vaccine for Influenza Sales Share by Country (2019-2030)

Figure 48. Germany Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 49. France Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 50. U.K. Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 51. Italy Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 52. Russia Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 53. China Vaccine for Influenza Sales Market Share by Type (2019-2030)

Figure 54. China Vaccine for Influenza Revenue Market Share by Type (2019-2030)

Figure 55. China Vaccine for Influenza Sales Market Share by Application (2019-2030)

Figure 56. China Vaccine for Influenza Revenue Market Share by Application (2019-2030)

Figure 57. Asia Vaccine for Influenza Sales Market Share by Type (2019-2030)

Figure 58. Asia Vaccine for Influenza Revenue Market Share by Type (2019-2030)

Figure 59. Asia Vaccine for Influenza Sales Market Share by Application (2019-2030)

Figure 60. Asia Vaccine for Influenza Revenue Market Share by Application (2019-2030)

Figure 61. Asia Vaccine for Influenza Revenue Share by Region (2019-2030)

Figure 62. Asia Vaccine for Influenza Sales Share by Region (2019-2030)

Figure 63. Japan Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 64. South Korea Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 65. China Taiwan Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 66. Southeast Asia Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 67. India Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 68. Middle East, Africa and Latin America Vaccine for Influenza Sales Market Share by Type (2019-2030)

Figure 69. Middle East, Africa and Latin America Vaccine for Influenza Revenue Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Vaccine for Influenza Sales Market Share by Application (2019-2030)

Figure 71. Middle East, Africa and Latin America Vaccine for Influenza Revenue Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Vaccine for Influenza Revenue Share by Country (2019-2030)

Figure 73. Middle East, Africa and Latin America Vaccine for Influenza Sales Share by Country (2019-2030)

Figure 74. Brazil Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 75. Mexico Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 76. Turkey Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 77. Israel Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 78. GCC Countries Vaccine for Influenza Revenue (2019-2030) & (US$ Million)

Figure 79. Vaccine for Influenza Value Chain

Figure 80. Vaccine for Influenza Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions